z-logo
open-access-imgOpen Access
Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants
Author(s) -
Ceejay L. Boyce,
Tatiana Sils,
Daisy Ko,
Annie Wong-On-Wing,
Ingrid A. Beck,
Sheila Styrchak,
Patricia DeMarrais,
Camlin Tierney,
Lynda StranixChibanda,
Patricia M. Flynn,
Taha E. Taha,
Maxensia Owor,
Mary Glenn Fowler,
Lisa M. Frenkel
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab744
Subject(s) - breastfeeding , medicine , nevirapine , transmission (telecommunications) , viral load , drug resistance , breast feeding , hiv drug resistance , pregnancy , immunology , pediatrics , virology , virus , antiretroviral therapy , biology , genetics , microbiology and biotechnology , electrical engineering , engineering
We aimed to assess if maternal human immunodeficiency virus (HIV) drug resistance is associated with an increased risk of HIV vertical transmission and to describe the dynamics of drug resistance in HIV-infected infants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom